Asia Pacific Melanoma therapeutics market growing at a CAGR of 16.40%

“Asia Pacific Melanoma Therapeutics market" research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 16.40% to reach USD 1.24 billion by 2021, from USD 0.58 billion in 2016.

The American Cancer Society estimates that 87,110 new Melanomas will be diagnosed this year, 60% in men and 40% in women. Over the last 30 years, the risk of getting Melanoma has been rising. As people age, they are at a higher risk of developing Melanoma, the average age of the people diagnosed being 63 but it is also one of the most common cancers in young adults (especially young women). The outlook for the people with Melanoma varies with the stage or extent of the cancer, with the 5-year survival rate for stage 1 being more than 95% and the 5-year survival rate for stage IV being less than 20%.

Request Sample: http://www.marketdataforecast.com/market-reports/asia-pacific-melanoma-therapeutics-market-854/request-sample

The report presents a detailed analysis of multitude of factors affecting the melanoma therapeutics market bearing either positive or negative outcomes. Some of those factors are

• Growing population
• Rise in ageing population
• Increased prevalence of Melanoma
• Volatile economies
• Poor accessibility to proper cancer care
• Limited awareness
• Increased exposure to UV radiation

For granular level understanding the Melanoma Therapeutics market is segmented based on cancer stage, cancer type, diagnosis, and treatment. On the basis of cancer stage it is segmented into Stage 0, Stage I, Stage II, Stage III, and Stage IV. On the basis of cancer type, the market is segmented into Nodular Melanoma, Acral lentiginous melanoma, superficial spreading melanoma, lentigno maligna melanoma, amelanotic melanoma, and others. The market is also segmented on the basis of method of diagnosis into ultrasound, blood tests, dermatoscopy, sentinel lymph node biopsy, X-rays, and CT scans. On the basis of treatment methods, the market is first segmented into treatment methods for early melanoma and those for advanced melanoma. The treatment for advanced melanoma is further sub-segmented into Biological therapy, Targeted therapy, surgery, Chemotherapy, radiotherapy, and immunotherapy. Among the above, chemotherapy is the most common method of treatment and occupies the largest market share.
The Asia Pacific market has been geographically segmented into China, India, japan, South Korea, and Australia. China currently has the highest market share in the region, followed by India owing to the general state of the healthcare industry in the countries and the populations within them. In the global market, the Asia-pacific region is expected to be growing at the fastest rate.

Enquire about the report: http://www.marketdataforecast.com/market-reports/asia-pacific-melanoma-therapeutics-market-854/inquire
The major companies that have a wide product portfolio of treatment options available are Bristol-Myers Squibb Co., Merck, Roche, Amgen, Pfizer, and Daiichi Sankyo, to name a few. They have many products in their pipeline and are constantly seeking new technologies that would make treatment of cancers easier

For more reports related to cancer:

Asia Pacific Tumor Ablation market: http://www.marketdataforecast.com/market-reports/asia-pacific-tumor-ablation-market-476/

About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

This release was published on openPR.